"Vitamin A" from_date:2012

Vitamin B12 deficiency in over 16s: diagnosis and management Vitamin B12 deficiency in over 16s: diagnosis and management NICE guideline Published: 6 March 2024 www.nice.org.uk/guidance/ng239 © NICE 2024. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of-rights).Your responsibility The recommendations in this guideline represent the view inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with complying with those duties. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Vitamin B12 deficiency in over 16s: diagnosis

Early detection of vitamin B12 deficiency and other target diseases (homocystinuria, propionic acidaemia and methylmalonic acidaemia) in extended newborn screening (ENS) 1 Translation of Chapters 1 to 6 of the final report S22-02 Früherkennung eines Vitamin-B12-Mangels und weiterer Zielerkrankungen (Homocystinurie, Propionazidämie und Methylmalonazidurie) im erweiterten Neugeborenenscreening (ENS) (Version 1.0; Status: 5 February 2024 [German original], 22 August 2024 [English translation]). Please note: This document is provided as a service by IQWiG to English-language readers. However, solely the German original text is absolutely authoritative and legally binding. Screening for vitamin B12 deficiency and other target diseases (homocystinuria, propionic acidaemia and methylmalonic

Evaluation of the Healthy Start voucher scheme on maternal vitamin use and child breastfeeding: a natural experiment using data linkage Text onlyJournals LibraryNHS NIHR - National Institute for Health and Care ResearchSelectEMEGHRHSDRHTAPGfARPHR AdvancedJournalsEfficacy and Mechanism EvaluationGlobal Health ResearchHealth and Social Care Delivery ResearchHealth Technology AssessmentProgramme Grants for Applied ResearchPublic Health ResearchTwitterFacebookLinkedInEmailHome >> Journals >> Public Health Research >> Volume 11 >> Issue 11ToolkitDownload report PDFDownload report documentsDisclosure of interestDownload report XMLCitation ToolsPrintResponses to this report (0)Permissions informationVIEW AWARDEvaluation of the Healthy Start voucher scheme on maternal vitamin use and child

Vitamin C deficiency Vitamin C deficiency - Symptoms, diagnosis and treatment | BMJ Best PracticeSkip to main contentSkip to search * English (US)EnglishPortuguês中文 * Log in * Personal account * Access through your institution(Open Athens) * Subscribe * Access through your institution * Log in * English (US)EnglishPortuguês中文 HomeSearchSearchHome * About usOverviewWhat is BMJ Best Practice?Our , encephalopathy, and entrapment neuropathies. If not treated promptly, scurvy can be fatal. Complete recovery is anticipated in most patients. DefinitionScurvy is a life-threatening clinical syndrome due to dietary vitamin C (ascorbic acid) deficiency. Those affected are mostly refugees or victims of famine, older people, individuals with a history of alcohol misuse or an atypical diet, or children with autism

Routine Administration of Vitamin K1 Prophylaxis to the Newborn Routine Administration of Vitamin K1 Prophylaxis to the NewbornPractice Resource for Health Care ProvidersJuly 2016Perinatal Services BC Routine Administration of Vitamin K1 Prophylaxis to the Newborn 2 Practice Resource Guide: ROUTINE ADMINISTRATION OF VITAMIN K1 PROPHYLAXIS TO THE NEWBORNThe information attached is the summary of the position statement and the recommendations from the recent CPS evidence-based guideline for routine intramuscular administration of Vitamin K1 prophylaxis to the newborn*: www.cps.ca/documents/position/administration-vitamin-K-newbornsSummaryVitamin K deficiency bleeding or VKDB (formerly known as hemorrhagic disease of the newborn or HDNB) is significant bleeding which results from the newborn’s

Vitamin D deficiency Skip to main contentSkip to searchAbout usHelpSubscribeAccess through your institutionLog inBMJ Best PracticeSearchSearchSelect languageVitamin D deficiency MENULog in or subscribe to access all of BMJ Best PracticeLast reviewed:28 May 2023Last updated:22 Jun 2023SummaryVitamin D deficiency is the most common nutritional deficiency worldwide, characterised by serum 25 -hydroxyvitamin D <50 nanomoles/L (<20 nanograms/mL). Vitamin D insufficiency is regarded as a serum 25-hydroxyvitamin D concentration between 52-72 nanomoles/L (21-29 nanograms/mL).Main causes include sun avoidance, using sun protection, increased skin pigmentation, inadequate dietary and supplemental vitamin D intake, malabsorption syndromes, obesity, and medication use. Acquired and inherited disorders

Vitamin B12 deficiency Skip to main contentSkip to searchAbout usHelpSubscribeAccess through your institutionLog inBMJ Best PracticeSearchSearchSelect languageVitamin B12 deficiency MENULog in or subscribe to access all of BMJ Best PracticeLast reviewed:23 Jul 2023Last updated:22 Aug 2023SummaryVitamin B12 (cobalamin) deficiency classically presents with megaloblastic anaemia, but can also of the spinal cord, and dementia.Methylmalonic acid and homocysteine levels may help to diagnose vitamin B12 deficiency at an early, asymptomatic state.Cause of vitamin B12 deficiency should be searched for once a diagnosis is confirmed.Treatment with high-dose oral vitamin B12 therapy may be as effective as intramuscular vitamin B12 therapy.DefinitionVitamin B12 is an essential vitamin; deficiency generally

Vitamin B3 deficiency Skip to main contentSkip to searchLog inEnglish#{autosuggest.search}#{autosuggest.search}Vitamin B3 deficiency MENULog in or subscribe to access all of BMJ Best PracticeLast reviewed:27 Nov 2023Last updated:21 Dec 2023SummaryVitamin B3 deficiency is traditionally caused by consuming a diet mainly composed of corn and maize.Severe deficiency leads to pellagra, which is characterised by dermatitis, dementia, diarrhoea, and eventually death.Lean meat, poultry, fish, and peanuts are rich in vitamin B3 (niacin); milk and eggs are rich sources of tryptophan, the precursor of niacin.Deficiency of vitamins B2 (riboflavin) and/or B6 (pyridoxine) reduces the synthesis of niacin from tryptophan and may lead to secondary vitamin B3 deficiency.Rare in developed countries, although

Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Age-related macular degeneration (AMD) is a degenerative condition of the back of the eye that occurs in people over the age of 50 years. Antioxidants may prevent cellular damage in the retina by reacting with free radicals that are produced in the process of light absorption. Higher dietary levels of antioxidant vitamins and minerals may reduce the risk of progression of AMD. This is the third update of the review. To assess the effects of antioxidant vitamin and mineral supplements on the progression of AMD in people with AMD. We searched CENTRAL, MEDLINE, Embase, one other database, and three trials registers, most recently on 29 November 2022. We included randomised controlled

Calcium and vitamin D for increasing bone mineral density in premenopausal women. Osteoporosis is a condition where bones become fragile due to low bone density and impaired bone quality. This results in fractures that lead to higher morbidity and reduced quality of life. Osteoporosis is considered a major public health concern worldwide. For this reason, preventive measurements need to be addressed throughout the life course. Exercise and a healthy diet are among the lifestyle factors that can help prevent the disease, the latter including intake of key micronutrients for bone, such as calcium and vitamin D. The evidence on whether supplementation with calcium and vitamin D improves bone mineral density (BMD) in premenopausal women is still inconclusive. In this age group, bone accrual

Oral vitamin D supplementation: dangerous overdoses caused by errors Register online | Log in | My PrescrireISSUE CONTENTSTOPICSABOUT PRESCRIREOFFERSenglish.prescrire.org > Spotlight > 100 most recent > Oral vitamin D supplementation: dangerous overdoses caused by errorsSpotlightEvery month, the subjects in Prescrire’s Spotlight.100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80  | 90Spotlight100 most recentArchivesOral vitamin D supplementation: dangerous overdoses caused by errors Adverse Effects  Vitamin D overdose exposes patients to the risk of hypercalcaemia and hyperphosphataemia, and their sometimes serious or even fatal adverse effects, including: thirst, polyuria, anorexia, constipation, muscle weakness, fatigue, nausea and vomiting, confusion and renal disorders.Full article

Cobalamin (vitamin B12) and Folate Deficiency Skip to main contentSkip to main navigationSkip to side navigationAccessibility StatementMenuHome Health Practitioner & Professional Resources BC GuidelinesAbout the GuidelinesExternal Review of GuidelinesContinuing Professional Development (CPD) CreditsGuidelines by Alphabetical ListingPartner GuidelinesGuidelines Eligible for Incentive PaymentsAddictions and Substance UseGuidelines by TopicCardiovascularDiagnostic ImagingHigh Ferritin and Iron OverloadEmergencyEndocrine SystemGastrointestinal SystemGeriatric MedicineHead and NeckLaboratoryMental HealthOncologyPediatricPalliative CarePreventative HealthRespiratory SystemRheumatological and Musculoskeletal SystemsUrological SystemChronic PainCobalamin (vitamin B12) and Folate DeficiencyRevised

Monitoring the vitamin D package measure Go to contentYou are here:HomePublicationsMonitoring the vitamin D package measureSearch within English part of National Health Care InstituteOpen search boxMonitoring the vitamin D package measureThe Minister of Health, Welfare and Sport (VWS) decided, on the advice of the National Health Care Institute, to discontinue the reimbursement of all vitamin D products containing cholecalciferol or calcifediol from 1 January 2023. Nivel, the Netherlands Institute for Health Services Research, has investigated the effects of this package measure on the use of vitamin D by vulnerable groups. The National Health Care Institute concludes that the results of the study do not change our 2022 recommendation not to reimburse vitamin D from the Medicine Reimbursement

Vitamin B12 (hydroxocobalamin, cyanocobalamin): advise patients with known cobalt allergy to be vigilant for sensitivity reactions Skip to main contentCookies on GOV.UKWe use some essential cookies to make this website work.We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.We also use cookies set by other sites to help us deliver content from their services.Accept additional cookiesReject additional cookiesView cookies GOV.UK Navigation menu Menu Search GOV.UK HomeDrug Safety UpdateVitamin B12 (hydroxocobalamin, cyanocobalamin): advise patients with known cobalt allergy to be vigilant for sensitivity reactionsThe medicines used to treat vitamin B12 deficiency (hydroxocobalamin, cyanocobalamin) contain cobalt

Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline | The Journal of Clinical Endocrinology & Metabolism | Oxford Academic Skip to Main Content Advertisement Journals Books * Search Menu * * * Menu * * * Sign in through your institution Navbar Search Filter The Journal Advanced Search Search Menu Article Navigation Close mobile search navigation Article Navigation Article Contents * Abstract * Introduction * Limitations * List of Recommendations * Methods of Development of Evidence-Based Clinical Practice Guidelines * Evidence-to-Decision Considerations Common to Multiple Clinical Questions * Vitamin D Use for Children Aged 1 to 18 Years * Vitamin D Use in Nonpregnant

Does vitamin D prevent fragility fractures? #374 Vitamin D and Fracture Prevention: Not what it’s cracked up to be? – CFPCLearn Credits Earned (2024) Crédits obtenus * Learn * * Apprendre * * * Tools for practice * Videos * Podcasts * ECourses * Search * Recherche * ?Help * ?Aider Redeem Prepaid Membership * * English * Français * Sign In * Join Now * Ouvrir une session * S’inscrire maintenant Membership Account Membership Credit History Edit Profile Sign Out Tools for PracticeOutils pour la pratique << Previous << Précédent Back to Tools For Practice Retour à Outils pour la pratique * #374 Vitamin D and Fracture Prevention: Not what it’s cracked up to be? CLINICAL QUESTION QUESTION CLINIQUEDoes vitamin D prevent fragility fractures? BOTTOM LINE RÉSULTAT FINALVitamin D alone does not prevent

Is There a Role for Vitamins in the Management of Alcohol Use Disorder? Is There a Role for Vitamins in the Management of Alcohol Use Disorder? – Clinical Correlations Clinical Correlations * AboutAboutAwardsPeer Review * CategoriesBedside RoundsChiefs' Inquiry CornerCORE IM PodcastDiseases 2.0EthicsEvolution and MedicineGamechanger?Healthcare PolicyHotSpotsMystery QuizMyths and RealitiesPrimeCutsSpotlightSee All Categories * SystemsAllergy/ImmunologyCardiologyDermatologyEndocrineGeriatricsGIHeme/OncIDMusculoskeletalNeuroNutritionPain/PalliativePsychiatryPulmonary/Critical CareRadiologyRenalRheumatologyUrology * Subscribe Search Is There a Role for Vitamins in the Management of Alcohol Use Disorder?November 1, 2024 Clinical Questions Uncategorized 6 min read | Twitter | Facebook | EmailBy Chloe Fong

COVID-19 rapid guideline: vitamin D COVID-19 rapid guideline: vitamin D NICE guideline Published: 17 December 2020 www.nice.org.uk/guidance/ng187 © NICE 2022. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of-rights).Your responsibility Your responsibility The recommendations in this guideline represent the view of NICE, arrived at after assess and reduce the environmental impact of implementing NICE recommendations wherever possible. COVID-19 rapid guideline: vitamin D (NG187)© NICE 2022. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of-rights).Page 2 of15Contents Contents Overview

Vitamin D drops for infants: mistakes to avoid Prescrire IN ENGLISH - Spotlight ''Vitamin D drops for infants: mistakes to avoid'', 1 January 2022 {1}##LOC[OK]## {1} ##LOC[OK]## ##LOC[Cancel]## {1}##LOC[OK]####LOC[Cancel]## Register online| Log in| My Prescrire Issue contents * Current issue * Last 12 issues * All issues Topics * Annual Prescrire Awards * Advancing healthcare policy * Prescrire's other products * Free Special Edition * Sign up to receive the newsletter english.prescrire.org > Spotlight > 100 most recent > Vitamin D drops for infants: mistakes to avoid SpotlightEvery month, the subjects in Prescrire’s Spotlight. 100 most recent: 1|10|20|30|40|50|60|70|80|90Spotlight * 100 most recent * ArchivesVitamin D drops for infants: mistakes to avoid

What Is the Efficacy and Safety of Direct Oral Anticoagulants Compared to Vitamin K Antagonists in Patients With Cerebral Vein Thrombosis? Skip to Main ContentLog inNEUROLOGY/SYSTEMATIC REVIEW SNAPSHOT| VOLUME 80, ISSUE 4, P329-331, OCTOBER 01, 2022What Is the Efficacy and Safety of Direct Oral Anticoagulants Compared With that of Vitamin K Antagonists in Patients With Cerebral Vein Thrombosis % (0.33%-2.22%) 1.22 (0.32-4.59) 0%Major bleeding 2.54% (0.94%-4.81%) 2.72% (0.86%-5.46%) 0.79 (0.33-1.86) 0%Recurrent VTE 2.02% (0.75%-3.83%) 2.01% (0.40%-4.60%) 0.67 (0.26-1.75) 0%Excellent neurologic outcome 82.4% (72.9%-90.3%) 75.7% (64.3%-85.6%) 1.06 (0.96-1.17) 14.2%Vessel recanalization 84.9% (76.4%-91.8%) 85.1% (77.0%-91.7%) 1.00 (0.95-1.06) 0%VKA, Vitamin K antagonist; RR, risk ratio; CI